Optimal Ranges
Clinical (NHS) Range
0-41 U/L
U/L
Performance-Optimised Range
10-26 U/L
U/L
The clinical range defines what is considered medically “normal” — broad enough to cover 95% of the population. The performance range reflects where research and clinical experience suggest most people feel and function at their best.
Why It Matters
Why ALT matters for performance
Your liver is the body's detoxification centre, metabolising everything from alcohol and paracetamol to protein and hormones. Elevated ALT often appears long before symptoms — catching liver stress early is critical. For active men, ALT can be mildly elevated after intense exercise (particularly resistance training), so timing matters. More concerning elevations indicate fatty liver disease (NAFLD), which affects an estimated 25-30% of UK adults and is the leading cause of liver disease in the developed world. NAFLD is strongly linked to insulin resistance and visceral fat, making ALT a valuable metabolic screening marker.
Symptoms
Signs your levels may be off
Low / Deficiency
- ALT that is too low is rare and generally not clinically significant
High / Excess
- Often asymptomatic in early stages
- Fatigue and malaise
- Abdominal discomfort (right upper quadrant)
- Nausea and loss of appetite
- Jaundice (yellowing of skin/eyes) in severe cases
Dietary Sources
Foods that support ALT levels
Supplementation
Evidence-based supplementation
There are no supplements that directly lower ALT — the goal is to address the underlying cause. For fatty liver: weight loss of 5-10% body weight is the most effective intervention, combined with reduced sugar intake and regular exercise. Milk thistle (silymarin) is widely marketed for liver health but evidence is mixed; it may offer modest benefit in specific liver conditions. NAC (N-acetylcysteine) supports glutathione production and is used clinically for paracetamol overdose but evidence for general liver protection is limited. The best approach is lifestyle: moderate alcohol, healthy weight, regular exercise, and adequate sleep.
Research
Key study
Global epidemiology of nonalcoholic fatty liver disease — meta-analytic assessment of prevalence, incidence, and outcomes
Younossi ZM, Koenig AB, Abdelatif D, et al.
Hepatology (2016)
DOI: 10.1002/hep.28431Related Biomarkers
Related Guides
Test your ALT levels
ALT is included in the Helvy 50+ biomarker panel. Get your results in 5 days with a personalised protocol.
Order Your TestThis content is for educational purposes only and does not constitute medical advice. Your data suggests areas for optimisation, but any concerns should be discussed with a qualified healthcare professional. If your results flag values outside safe ranges, we recommend consulting your GP.